| Dr Scott Edwin Strasburger, MD | |
|
7121 Stephanie Ln, Suite 100, Lincoln, NE 68516-5359 | |
| (402) 466-0100 | |
| (402) 466-0458 |
| Full Name | Dr Scott Edwin Strasburger |
|---|---|
| Gender | Male |
| Speciality | Orthopedic Surgery |
| Experience | 25 Years |
| Location | 7121 Stephanie Ln, Lincoln, Nebraska |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1851340525 | NPI | - | NPPES |
| 209332006 | Medicaid | MO | |
| 47070309913 | Medicaid | NE |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207XX0005X | Orthopaedic Surgery - Sports Medicine | 20145 (Nebraska) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Syracuse Area Health | Syracuse, NE | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Community Memorial Hospital District | 7517856859 | 24 |
News Archive
Despite modest overall improvements in breast cancer survival rates for women with advanced disease over the last two decades, the rates for black women have not improved and the difference in life expectancy between white and black women continues to widen, according to researchers at The University of Texas M. D. Anderson Cancer Center.
Goserelin, a lutenizing hormone-releasing hormone agonist, reduces the long-term risk of disease recurrence and deaths in premenopausal women with early breast cancer who did not take tamoxifen, according to trial data reported in the February 24 online issue of the Journal of the National Cancer Institute.
Penn Medicine will conduct the Northeast's first clinical trial of uterine transplants, to provide women with Uterine Factor Infertility (UFI) - an irreversible form of female infertility that affects as many as 5 percent of women worldwide and 50,000 women in the United States - with a new path to parenthood.
EpiCept Corporation today announced that it has reached an agreement on all outstanding issues with the U.S. Food and Drug Administration (FDA) on a regulatory path forward for Ceplene® (histamine dihydrochloride), the Company's lead product for the remission maintenance and prevention of relapse of patients with acute myeloid leukemia (AML) in first complete remission. Ceplene® is approved in the European Union for this indication and is marketed there by Meda AB.
› Verified 5 days ago
| Entity Name | Community Memorial Hospital District |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1336155134 PECOS PAC ID: 7517856859 Enrollment ID: O20040313000441 |
News Archive
Despite modest overall improvements in breast cancer survival rates for women with advanced disease over the last two decades, the rates for black women have not improved and the difference in life expectancy between white and black women continues to widen, according to researchers at The University of Texas M. D. Anderson Cancer Center.
Goserelin, a lutenizing hormone-releasing hormone agonist, reduces the long-term risk of disease recurrence and deaths in premenopausal women with early breast cancer who did not take tamoxifen, according to trial data reported in the February 24 online issue of the Journal of the National Cancer Institute.
Penn Medicine will conduct the Northeast's first clinical trial of uterine transplants, to provide women with Uterine Factor Infertility (UFI) - an irreversible form of female infertility that affects as many as 5 percent of women worldwide and 50,000 women in the United States - with a new path to parenthood.
EpiCept Corporation today announced that it has reached an agreement on all outstanding issues with the U.S. Food and Drug Administration (FDA) on a regulatory path forward for Ceplene® (histamine dihydrochloride), the Company's lead product for the remission maintenance and prevention of relapse of patients with acute myeloid leukemia (AML) in first complete remission. Ceplene® is approved in the European Union for this indication and is marketed there by Meda AB.
› Verified 5 days ago
| Entity Name | Community Memorial Hospital District |
|---|---|
| Entity Type | Part A Provider - Critical Access Hospital |
| Entity Identifiers | NPI Number: 1013925924 PECOS PAC ID: 7517856859 Enrollment ID: O20071127000849 |
News Archive
Despite modest overall improvements in breast cancer survival rates for women with advanced disease over the last two decades, the rates for black women have not improved and the difference in life expectancy between white and black women continues to widen, according to researchers at The University of Texas M. D. Anderson Cancer Center.
Goserelin, a lutenizing hormone-releasing hormone agonist, reduces the long-term risk of disease recurrence and deaths in premenopausal women with early breast cancer who did not take tamoxifen, according to trial data reported in the February 24 online issue of the Journal of the National Cancer Institute.
Penn Medicine will conduct the Northeast's first clinical trial of uterine transplants, to provide women with Uterine Factor Infertility (UFI) - an irreversible form of female infertility that affects as many as 5 percent of women worldwide and 50,000 women in the United States - with a new path to parenthood.
EpiCept Corporation today announced that it has reached an agreement on all outstanding issues with the U.S. Food and Drug Administration (FDA) on a regulatory path forward for Ceplene® (histamine dihydrochloride), the Company's lead product for the remission maintenance and prevention of relapse of patients with acute myeloid leukemia (AML) in first complete remission. Ceplene® is approved in the European Union for this indication and is marketed there by Meda AB.
› Verified 5 days ago
| Entity Name | Strasburger Orthopaedics Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1750704342 PECOS PAC ID: 1850522681 Enrollment ID: O20140320000849 |
News Archive
Despite modest overall improvements in breast cancer survival rates for women with advanced disease over the last two decades, the rates for black women have not improved and the difference in life expectancy between white and black women continues to widen, according to researchers at The University of Texas M. D. Anderson Cancer Center.
Goserelin, a lutenizing hormone-releasing hormone agonist, reduces the long-term risk of disease recurrence and deaths in premenopausal women with early breast cancer who did not take tamoxifen, according to trial data reported in the February 24 online issue of the Journal of the National Cancer Institute.
Penn Medicine will conduct the Northeast's first clinical trial of uterine transplants, to provide women with Uterine Factor Infertility (UFI) - an irreversible form of female infertility that affects as many as 5 percent of women worldwide and 50,000 women in the United States - with a new path to parenthood.
EpiCept Corporation today announced that it has reached an agreement on all outstanding issues with the U.S. Food and Drug Administration (FDA) on a regulatory path forward for Ceplene® (histamine dihydrochloride), the Company's lead product for the remission maintenance and prevention of relapse of patients with acute myeloid leukemia (AML) in first complete remission. Ceplene® is approved in the European Union for this indication and is marketed there by Meda AB.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Scott Edwin Strasburger, MD 7121 Stephanie Ln, Suite 100, Lincoln, NE 68516-5359 Ph: (402) 466-0100 | Dr Scott Edwin Strasburger, MD 7121 Stephanie Ln, Suite 100, Lincoln, NE 68516-5359 Ph: (402) 466-0100 |
News Archive
Despite modest overall improvements in breast cancer survival rates for women with advanced disease over the last two decades, the rates for black women have not improved and the difference in life expectancy between white and black women continues to widen, according to researchers at The University of Texas M. D. Anderson Cancer Center.
Goserelin, a lutenizing hormone-releasing hormone agonist, reduces the long-term risk of disease recurrence and deaths in premenopausal women with early breast cancer who did not take tamoxifen, according to trial data reported in the February 24 online issue of the Journal of the National Cancer Institute.
Penn Medicine will conduct the Northeast's first clinical trial of uterine transplants, to provide women with Uterine Factor Infertility (UFI) - an irreversible form of female infertility that affects as many as 5 percent of women worldwide and 50,000 women in the United States - with a new path to parenthood.
EpiCept Corporation today announced that it has reached an agreement on all outstanding issues with the U.S. Food and Drug Administration (FDA) on a regulatory path forward for Ceplene® (histamine dihydrochloride), the Company's lead product for the remission maintenance and prevention of relapse of patients with acute myeloid leukemia (AML) in first complete remission. Ceplene® is approved in the European Union for this indication and is marketed there by Meda AB.
› Verified 5 days ago
Dr. Nicholas Kristian Gove, M.D. Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 6900 A St, Suite 100, Lincoln, NE 68510 Phone: 402-436-2000 Fax: 402-434-2691 | |
Dr. Daniel Ray Ripa, MD Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: Nebraska Orthopaedic And Sports Medicine P.c., 575 S. 70th Suite 200, Lincoln, NE 68510 Phone: 402-488-3322 Fax: 402-488-1172 | |
Dr. Scott D Bigelow, M.D. Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 6900 A St Ste 100, Lincoln, NE 68510 Phone: 402-436-2000 Fax: 402-434-2691 | |
Dr. David Patrick Heiser, MD Orthopedic Surgery Medicare: Not Enrolled in Medicare Practice Location: 575 S 70th, Ste 200, Nebraska Orthopaedic And Sports Medicine Pd, Lincoln, NE 68510 Phone: 402-488-3322 Fax: 402-488-1172 | |
Benjamin Micheal Woodhead, D.O. Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 6900 A St Ste 100, Lincoln, NE 68510 Phone: 402-436-2000 Fax: 402-436-2086 | |
Dr. Geoffrey M Mccullen, MD Orthopedic Surgery Medicare: Not Enrolled in Medicare Practice Location: 6900 A St, Lincoln, Lincoln, NE 68510 Phone: 402-436-2000 Fax: 402-436-2090 | |
William Naylor, DO Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: Bryan Physician Network, 2300 S 16th St, Lincoln, NE 68502 Phone: 402-481-5860 |